Latest Insider Transactions at Bluebird Bio, Inc. (BLUE)
This section provides a real-time view of insider transactions for Bluebird Bio, Inc. (BLUE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of bluebird bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of bluebird bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2021
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
1,287
-2.98%
|
$57,915
$45.11 P/Share
|
|
Jan 06
2021
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
2,358
-3.41%
|
$106,110
$45.11 P/Share
|
|
Jan 06
2021
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,167
-4.09%
|
$142,515
$45.11 P/Share
|
|
Jan 06
2021
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,814
-3.43%
|
$81,630
$45.11 P/Share
|
|
Jan 06
2021
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
10,095
-5.32%
|
$454,275
$45.11 P/Share
|
|
Jan 05
2021
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
45
-0.13%
|
$1,980
$44.95 P/Share
|
|
Jan 05
2021
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
42
-0.19%
|
$1,848
$44.95 P/Share
|
|
Jan 05
2021
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
43
-0.12%
|
$1,892
$44.95 P/Share
|
|
Jan 05
2021
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
48
-0.12%
|
$2,112
$44.95 P/Share
|
|
Jan 05
2021
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
40
-0.15%
|
$1,760
$44.95 P/Share
|
|
Jan 05
2021
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
333
-0.34%
|
$14,652
$44.95 P/Share
|
|
Dec 03
2020
|
Katy Burnett Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
123
-7.77%
|
$5,658
$46.09 P/Share
|
|
Dec 02
2020
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
444
-0.23%
|
$20,424
$46.34 P/Share
|
|
Dec 02
2020
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
64
-0.08%
|
$2,944
$46.34 P/Share
|
|
Dec 02
2020
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
59
-0.08%
|
$2,714
$46.34 P/Share
|
|
Dec 02
2020
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
38
-0.05%
|
$1,748
$46.34 P/Share
|
|
Dec 02
2020
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
38
-0.09%
|
$1,748
$46.34 P/Share
|
|
Dec 02
2020
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
36
-0.07%
|
$1,656
$46.34 P/Share
|
|
Nov 02
2020
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
444
-0.15%
|
$23,532
$53.59 P/Share
|
|
Nov 02
2020
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
63
-0.05%
|
$3,339
$53.59 P/Share
|
|
Nov 02
2020
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
59
-0.05%
|
$3,127
$53.59 P/Share
|
|
Nov 02
2020
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
37
-0.03%
|
$1,961
$53.59 P/Share
|
|
Nov 02
2020
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
37
-0.06%
|
$1,961
$53.59 P/Share
|
|
Nov 02
2020
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
35
-0.04%
|
$1,855
$53.59 P/Share
|
|
Oct 02
2020
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
60
-0.17%
|
$3,120
$52.77 P/Share
|
|
Oct 02
2020
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
450
-0.45%
|
$23,400
$52.77 P/Share
|
|
Oct 02
2020
|
Alison Cecily Finger Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
36
-0.13%
|
$1,872
$52.77 P/Share
|
|
Oct 02
2020
|
Joanne Smith Farrell COO, Oncology |
SELL
Open market or private sale
|
Direct |
38
-0.17%
|
$1,976
$52.77 P/Share
|
|
Oct 02
2020
|
Jason Cole Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct |
38
-0.11%
|
$1,976
$52.77 P/Share
|
|
Oct 02
2020
|
David Davidson Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
64
-0.16%
|
$3,328
$52.77 P/Share
|